Description
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Location: CPMC (San Francisco)
Please contact: Clinical Research@suttehealth.org about study CymaBay CB8025-41837 AFFIRM